HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China

被引:21
作者
Qiu, Ai-Dong
Wu, En-Qi
Yu, Xiang-Hui
Jiang, Chun-Lai
Jin, Ying-Hua
Wu, Yong-Ge
Chen, Yue
Chen, Yan
Shan, Ya-Ming
Zhang, Guo-Nan
Fan, Ying
Zha, Xiao [1 ]
Kong, Wei
机构
[1] Sichuan Tumor Hosp, Dept Mol Pharmacol, Chengdu 610041, Peoples R China
[2] Sichuan Tumor Hosp, Dept Gynecol Oncol, Chengdu 610041, Peoples R China
[3] Jilin Univ, Coll Life Sci, Vaccines Res Ctr, Changchun 130012, Peoples R China
关键词
human papillomavirus; prevalence; E6; variation; physical state;
D O I
10.1016/j.ygyno.2006.07.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Infection with high-risk human papillomavirus (hr-HPV) is an important factor associated with cervical cancer. The genetic mutation of HPV16 E6 and integration of HPV16 DNA in the cervical carcinoma tissues are considered important genetic changes in cervical lesion progression. But the studies of hr-HPV epidemiology are relatively less in the area of Sichuan, China. Therefore, we investigated the prevalence of 9 high-risk subtypes and analyzed the genetic mutation characteristic of HPV16 E6 and physical state of HPV16 DNA. Methods. The fragments of L1 and E6 genes were amplified by PCR or nested PCR and then directly sequenced. Further, the multiplex PCR for HPV 16 E2 and E6 genes was performed for detection of integration. Results. HPV 16, 58 and 18 were prominent, accounting for 78.6%, 20.0% and 9.7%, respectively in 145 isolates. E6 variants revealed that the European (EP) prototype and East Asia (EA) strain were 26 (23.0%) and 34 (30.1%), respectively. Furthermore, there were 14 base substitutions in E6 regions of the study group, of which 12 resulted in amino acid changes and the rest was silent mutation. Significantly, the 240G substitution exactly located the P53 degradation site. Overall, 8 of 114 (7.0%) isolates only contained integrated HPV16 DNA, 43 (37.7%) only contained episomal DNA and 63 (55.3%) contained both integrated and episomal DNA. The proportion of disruption of an intact E2 gene in the patients with cervical cancer is much lower than that in the previous studies. Conclusions. HPV16, 58 and 18 were mainly prevailing subtypes in patients with cervical cancer from Sichuan areas, China and EP/EA strains were predominant in these areas. Some mutations of E6 gene, which lead to the amino acid changes, may be more potentially carcinogenic and the proportion of disruption of an intact E2 gene is much lower. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 64 条
[1]   Human papillomavirus infection among women in South and North Vietnam [J].
Anh, PTH ;
Hieu, NT ;
Herrero, R ;
Vaccarella, S ;
Smith, JS ;
Thuy, NT ;
Nga, NH ;
Duc, NB ;
Ashley, R ;
Snijders, PJF ;
Meijer, CJLM ;
Muñoz, N ;
Parkin, DM ;
Franceschi, S .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (02) :213-220
[2]   THE HUMAN PAPILLOMAVIRUS TYPE-18 (HPV18) E2 GENE-PRODUCT IS A REPRESSOR OF THE HPV18 REGULATORY REGION IN HUMAN KERATINOCYTES [J].
BERNARD, BA ;
BAILLY, C ;
LENOIR, MC ;
DARMON, M ;
THIERRY, F ;
YANIV, M .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4317-4324
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]  
BURGER RA, 1995, INT J ONCOL, V7, P261
[5]  
Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt
[6]  
232::AID-JMV18&gt
[7]  
3.0.CO
[8]  
2-7
[9]   ANALYSIS OF DELETION OF THE INTEGRATED HUMAN PAPILLOMAVIRUS-16 SEQUENCE IN CERVICAL-CANCER - A RAPID MULTIPLEX POLYMERASE CHAIN-REACTION APPROACH [J].
CHEN, CM ;
SHYU, MP ;
AU, LC ;
CHU, HW ;
CHENG, WTK ;
CHOO, KB .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (02) :206-211
[10]   Risk factors for cervical cancer in Thailand:: A case-control study [J].
Chichareon, S ;
Herrero, R ;
Muñoz, N ;
Bosch, FX ;
Jacobs, MV ;
Deacon, J ;
Santamaria, M ;
Chongsuvivatwong, V ;
Meijer, CJLM ;
Walboomers, JMM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) :50-57